Each year, influenza causes illness, hospitalizations and deaths, and severely strains the health care delivery system. This year, seasonal flu is complicated by the emergence and rapid spread of the H1N1 virus. In an effort to ensure that individuals and their families can take the appropriate actions to help protect themselves against the H1N1 virus, WellPoint's affiliated health plans will cover the administration of the H1N1 vaccine without co-pay or deductible for all health plan members. Plans also are encouraging self-insured employers to cover the cost of the vaccination for their employees.
"At WellPoint, our priority is to ensure that our actions and communications support public health," said Dr. Sam Nussbaum, WellPoint's chief medical officer. "Our goal is to keep our plan members as healthy as possible. We are committed to working with the CDC and HHS on an information campaign to ensure that members and the public are vaccinated to prevent H1N1, and if they develop H1N1 flu, they are treated effectively and appropriately."
Since a significant proportion of the vaccine is likely to be administered through non-traditional providers such as pharmacies, retail clinics and public health clinics, WellPoint's health plans are currently working to complete agreements with these providers to increase access to the H1N1 vaccine. In addition, the antiviral medications Tamiflu and Relenza will move to an economical tier in plan formularies.